SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the Mouth
Status:
Terminated
Trial end date:
2000-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the
development or recurrence of cancer. The use of fenretinide may be an effective way to
prevent the development of cancer in patients with neoplasia of the mouth.
PURPOSE: Phase II trial to study the effectiveness of fenretinide in preventing cancer in
patients who have neoplasia of the mouth.